156 related articles for article (PubMed ID: 14514394)
1. [CpG oligodeoxynucleotide enhances humoral and cellular immune responses against HBsAg in mice].
Zhou Z; Chen WS; Yao JL
Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):640-2. PubMed ID: 14514394
[TBL] [Abstract][Full Text] [Related]
2. CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.
Malanchère-Brès E; Payette PJ; Mancini M; Tiollais P; Davis HL; Michel ML
J Virol; 2001 Jul; 75(14):6482-91. PubMed ID: 11413315
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination.
Ma R; Du JL; Huang J; Wu CY
Biochem Biophys Res Commun; 2007 Sep; 361(2):537-42. PubMed ID: 17662694
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G; Benjamin P; Soita H; Babiuk LA
Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
[TBL] [Abstract][Full Text] [Related]
6. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
7. CpG ODN can re-direct the Th bias of established Th2 immune responses in adult and young mice.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Davis HL
FEMS Immunol Med Microbiol; 2001 Dec; 32(1):65-71. PubMed ID: 11750224
[TBL] [Abstract][Full Text] [Related]
8. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848).
Weeratna RD; Makinen SR; McCluskie MJ; Davis HL
Vaccine; 2005 Nov; 23(45):5263-70. PubMed ID: 16081189
[TBL] [Abstract][Full Text] [Related]
9. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.
Davis HL; Weeratna R; Waldschmidt TJ; Tygrett L; Schorr J; Krieg AM
J Immunol; 1998 Jan; 160(2):870-6. PubMed ID: 9551923
[TBL] [Abstract][Full Text] [Related]
10. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.
McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
FEMS Immunol Med Microbiol; 2002 Feb; 32(3):179-85. PubMed ID: 11934561
[TBL] [Abstract][Full Text] [Related]
11. CpG ODN enhances immunization effects of hepatitis B vaccine in aged mice.
Qin W; Jiang J; Chen Q; Yang N; Wang Y; Wei X; Ou R
Cell Mol Immunol; 2004 Apr; 1(2):148-52. PubMed ID: 16212903
[TBL] [Abstract][Full Text] [Related]
12. Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies.
Weeratna RD; Brazolot Millan CL; McCluskie MJ; Siegrist CA; Davis HL
FEMS Immunol Med Microbiol; 2001 Apr; 30(3):241-7. PubMed ID: 11335145
[TBL] [Abstract][Full Text] [Related]
13. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of immune responses to hepatitis B vaccine in immunodepressed mice by CpG oligodeoxynucleotide.
Qin WB; Jiang JW; Yang N; Chen QE; Wang YF; Wei XC; Ou RQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):647-50. PubMed ID: 15555425
[TBL] [Abstract][Full Text] [Related]
15. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.
Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N
Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626
[TBL] [Abstract][Full Text] [Related]
16. [Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients].
Xiang XX; Zhou XQ; Xie Q; Yu H; Zhou HJ
Zhonghua Gan Zang Bing Za Zhi; 2008 Feb; 16(2):97-100. PubMed ID: 18304423
[TBL] [Abstract][Full Text] [Related]
17. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
[TBL] [Abstract][Full Text] [Related]
18. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
[TBL] [Abstract][Full Text] [Related]
19. [Reciprocal priming-boosting role of HBsAg and DNA vaccines].
Zhou Z; Chen WS; Zhang HH; Yao JL
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517
[TBL] [Abstract][Full Text] [Related]
20. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
